Alteration of expression of Y chromosome-linked antigens in low immunogen cells
Disclosed herein are engineered cells and/or low immunogenic cells, including engineered cells and/or low immunogenic stem cells, engineered cells and/or low immunogenic cells differentiated therefrom, and engineered cells and/or low immunogenic CAR-T cells (primary or differentiated from engineered...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Disclosed herein are engineered cells and/or low immunogenic cells, including engineered cells and/or low immunogenic stem cells, engineered cells and/or low immunogenic cells differentiated therefrom, and engineered cells and/or low immunogenic CAR-T cells (primary or differentiated from engineered and/or low immunogenic stem cells), the present invention relates to engineered cells and/or low immunogen cells comprising reduced expression of one or more Y chromosome genes and reduced expression of MHC I and/or MHC II human leukocyte antigen molecules as well as over-expression of CD47, as well as related methods of their use and generation. Provided herein are cells that further exhibit reduced expression of T cell receptors.
本文公开了工程化细胞和/或低免疫原性细胞,其包括工程化细胞和/或低免疫原性干细胞、从其分化的工程化细胞和/或低免疫原性细胞以及工程化细胞和/或低免疫原性CAR-T细胞(原代或从工程化和/或低免疫原性干细胞分化),以及它们的使用和生成的相关方法,所述工程化细胞和/或低免疫原性细胞包含降低的一种或多种Y染色体基因的表达和降低的MHC I和/或MHC II人白细胞抗原分子的表达以及CD47的过表达。本文提供了细胞,其进一步表现出降低的T细胞受体的表达。 |
---|